Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We just wait for first deal. Everything changes overnight. We’ve seen bios go from .50 to 13 in weeks and then pull back and then if pipeline permits with other drugs it doubles and triples again and again. We have that TYPE of pipeline. Just need one! IMO.
Here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137620479
Industry: Biotech and Pharma
Revenue TTM: 100M to 2000M
Revenue Growth TMM over TTM: < 200 %, to cut off cos having a insane revenue jump TTM over TTM
Surprise: Average price to sales ratio still about 9 and average revenue growth 23 %.
Apply that to future IPIX with 1 B$ revenue from one drug with growth potential in excess of 23 % year over year, which IPIX should be able to achieve easily with the rest of its pipeline. You get potential (and conservative) market cap 9 billion. Let's assume 200 million share (now about 140 million).
That gives for potential (and conservative) share price 9000/200 = 45 bucks.
Version 2: Assume 15 % royalty income. That is 150 million. But this income goes directly to earnings (no cost of goods etc). Can't use price to sales ratio because it does not apply here. Must use P/E for 75 cent per share earnings. Screen gave average P/E 50.
That gives future IPIX (conservative) share price of 37.5 USD.
Someone posted with fully diluted share structure of 200mil 6 months back that a very successful P drug in the 35% pasi75 and mimicking Otezla revs would put the share price around $30....... brilacidin would be much more because of how many indications that are possible.
That’s an open loaded question and it will take years to get there. I feel blessed that I am still here adding 16K shares for 3k cash. Those one day I have zero doubt will be worth we’ll over 10 bucks. IMO.
I am asking Santa in order:
1. Receive BTD and do not PR
2. Make Term binding and PR partnership details.
3. Announce BTD to excite new BP followers/shareholders
4. Pay CRO and PR
5. Bring BP to Nov show
6. PR new BoD from BP
7. PR results to P phase 2b
8. PR meeting results from FDA meeting
9. PR Kevetrin Oral results
This is all doable in this year. Imo
Maybe MFO? :). But I got another 16000 shares! Thank you.....
They did not GET 10 million cash yet. They receive 1.9 million cash in the first 30 days. 2.2 -300k Read the filing. I’m in the camp hoping they are locking a deal after BTD. Then announce prior to conference and FDA meeting. Buy back preferred B and pay Cro. That is what I’m hopeful for
Just think big. Everyone says we are stuck with no trials. Well I think that ipix is about to gain a huge partner for OM (blue sky) and IBD (mucho billion) for starters!!! OM is first to market, Kevetrin and then Prurisol come back into the picture with funds, Prurisol may show to be powerful and steps up quick to next partner and phase 3 and then Kevetrin oral crushes. This will be a powerhouse stock. Just not tomorrow. Imo.
Exactly. So many unknowns......the cash could have taken Kevetrin through the final testing? It could have paid lawyer fees for the term sheet BP deal, could have produced brilacidin, could have reformulated B for IBD, or eczema. So many unknowns to be detailed soon........imo
I don’t think so. If this falls through there are others behind. Say Leo notifies this term sheet BP they just received a better offer......this BP says okay .... good luck. That means more time to go they next Term Sheet and DD. U have to get financing no matter what. U can’t just sit tight and think a deal will finalize. That would be a death sentence. Imo
It just takes one....new ball game!
Or just post facts about science
After everything is said and done per the filing the initial tranche would give Ipix 1.9 million cash. FYI.
Thank you for link. Was trying my best to lobby that a partner would be needed in one of these meetings ;)
Always trying to stay positive! It could still very well happen.
I don't think either Aspire or this MFO are longterm positives. I am 100% Bull on IPIX and have the share count to back that, but I don't think there is anything more to this than they got a discount off shares converting the Series B. I think they would sell shares for a 5% gain all day and I hope there are not shorting going on because I have been a apart of many Securities Purchase Agreements and the lenders want to make money and not be stuck holding the bag. They look for a 5% gain all day and quick. IMO
The key to everything here is Leo and Art to gain a partner with the resources to help push our pipeline forward. Why they have not done so yet? That is the million dollar question. My own thoughts are that we were close to 2 other deals which took months up months equaling years to get to the part where they were at and a deal fell through for whatever reason....better offer....better partner....IPIX asking too much.....waiting for data from other indications.......idk and no one but Leo and Art know.
Let's hope this Term Sheet player is the one and we solidify the sheet into a binding agreement! That is the hope here. If that happens, realistically all of our worries and fear and risk become chopped into bite size at that point. We have the drugs! They have proved out time and time again. We just need the muscle to push forward.
I'd hope and pray that BTD is the last marker and the deal is in place and waiting on that piece as it will bolster the deal for IPIX.
Love your posts TRYZ
End-of-Phase FDA. Does the company have to show a strong balance sheet for this type of meeting for the phase 3 talk? I thought a company has to show product, manufacturer, etc...I could not remember if they need to show how they plan to raise the money too or have the money?
TIA
Here is another THOUGHT KFC - - - - -
I will find a successful BIO investor and ask them to read all the PR's since 2015 and give them the Share Price at the end of 2014. They have no idea what the current share price or OS is now, but they will read all company PR's and SEC doc's
I wonder what their share price estimate would be? No online forums, etc...just PR's and SEC Doc's, blog,etc...
I don't have to tell you what I feel about you....so.....I have lost track of how much I have put into this...I am pissed it's this low and I am hopeful Leo and IPIX will come through. I understand the world we live in and know that these drugs matter and IPIX just needs to survive this negative long bear phase. I wish Art or Leo would respond to my emails but they are not. I would like to know many details. I invest and am standing behind my opinions and DD. I think IPIX will come out on top...I just want to get down at the firelight...pour some whiskey on this drowin man.
Let's go IPIX
Boom time - hopefully. Possible BP partner could spin this in a positive light and also take a nice stake at these low levels and make some good coin as they know how under valued the share price is. There are a 100 different scenarios that could play out with BP. Hopefully it’s a good friend of Art at Celgene or Pfizer
That’s what I’m saying dunner. I’d say let’s put that magical marker on the calendar. 84 days from now.
Reading several emails over the past year, I think there have been 2 significant deals that have fallen through. The positive as I interpreted...there was others who believed it was worth more and the process started over on 2 occasions that I am to believe. If/when a deal is inked those details might be in the filing. It’s been a long strange trip as Jery says. I’m hoping this term sheet partner is the one
I have seen what your are referring to as well...HOWEVER the D-UP411 WHAT's REALLY GOING TO HAPPEN starts here:
*What changed end of June? We received 2 MILLION in return for 8 MILLION shares. Had the chance to add more money if we hit milestones. We did not for many unknowns. If we hit those milestones we would have diluted 10-20 more million. *ballpark.
*As of May 6th 2018 we had just over 155 million OS. If you include that 8 Million shares for the 2mil cash our OS on June 29th was 163 Million.
*Looking at the prospectus today, we see that the OS was exactly that: 163.1 MILLION Shares OS as of Aug 27th!. So the entire freak out and OMG about what happened and the sky is falling...nothing else happened other than getting CASH for shares. The rest is history and no other shares can enter the market from that June 29th deal.
Fast forward ----- We miss all milestones per Aspire deal, the market freaks out about the 10K which stated they did not think they were going to hit the milestones, however stated that a NON-BINDING TERM SHEET was signed with a GLOBAL BP and not only for what we expected from the ASPIRE Agreement for B-OM with the expectations of double digit millions upfront, now we find out that a GLOBAL BP has signed a TERM SHEET for B-OM and ALSO B- IBD!!!! Something changed in those months. We find out this was now signed in August sometime.
We then find out that BREAKTHROUGH DESIGNATION is under review with the FDA in the middle/later September for B-OM!
Recap - What has happened here. We received 2 Million dollars for 8 Million shares. Nothing more we can hang our hat on at this point. We do not know if the 2 Mil went towards lawyer fees for the Term Sheet, we don't know if that money went to B manufacturing, we don't know if that 2 Mil went towards KEVETRIN ORAL testing, we do not know.
*Milestone D-Day passes - Sept 31st.
*October 9th - New 10 Million Financing Agreement with MFO. There is an initial phase where we will receive Approx 2.2 Million over first 30 days. We have issued 2000 Series B shares:
After giving effect to the sale of 2,000 shares of our Series B preferred stock for net proceeds of approximately $1.9 million after deducting estimated offering expenses payable by us, and assuming a conversion price of $0.238 per share, which was 85% of the closing price of our common stock on October 3, 2018 That means the OS increased by about 8.2 million more. So Currently the OS is approx 171 Million.
There is a clause in this offering:
Redemption Rights
Shares of Series B preferred stock are not otherwise entitled to any redemption rights, or mandatory sinking fund or analogous fund provisions, other than as set forth under “Triggering Events” below. Following 30 days after the closing, the Company may elect to redeem the Series B preferred stock for 120% of the aggregate stated value then outstanding, plus all accrued but unpaid dividends and all liquidated damages and other amounts due in respect of the Series B preferred stock. The Company’s right to redeem the Series B preferred stock is contingent upon it having complied with a number of conditions, including compliance with its obligations under the Certificate of Designation. -- Not saying this will happen but you never know!
---------------------------------------
Here it is. IPIX just raised 4 million dollars in 3-4 months for 16.2 million shares. All in the while, applied for BTD for B-OM. Sent in a request to meet with the FDA for end of phase meeting for B-OM (today), signed a Non Binding Term Sheet with a GLOBAL BP for OM and IBD :) also advised they are presenting at the Celegene conference for IBD in November.
If this is my company and these things play out.
We receive BTD in the next week or two, we sign the B-OM/IBD deal with BP, we announce the partnership at this IBD conference early in November and then take the BP with us to the FDA meeting for OM.
All while nothing significant has happened to our share structure or drugs in the past year and our stock price shoots right back up to 1-2-3-4 dollar land. Where it should be today. And who knows, maybe they have been working Kevetrin Oral in the background or drop the Prurisol results with this new set of financing. BOOM TIME BABY.
D-UPS 401 looks a whole bunch brighter
Share STRUCTURE per Prospectus.
Up to 208.5 million shares assuming sale of 10,000 shares of Series B preferred stock and conversion of such shares of Series B preferred stock into 45.4 million shares of our Class A common stock
163.1 million shares of Class A common stock outstanding as of August 27, 2018
FALSE:
This states and they all signed off they have had no such involvement:
4.15 Certain Transactions and Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the Signing Form 8-K
Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof.
We may grant underwriters who participate in the distribution of securities an option to purchase additional securities to cover overallotments, if any, in connection with the distribution. Any underwriter may engage in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with SEC orders, rules and regulations and applicable law. To the extent permitted by applicable law and SEC orders, rules and regulations, an overallotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. To the extent permitted by applicable law and SEC orders, rules and regulations, short covering transactions involve purchases of the common stock in the open market after the distribution is completed to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the common stock originally sold by the dealer is purchased in a covering transaction to cover short positions. Those activities may cause the price of the common stock to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.
The Company entered into a Securities Purchase Agreement pursuant to which the Company agreed to sell preferred stock that is convertible to its Class A common stock in a registered direct offering (the “Offering”), without an underwriter or placement agent.
I’ve never witnessed that but I would think that “if” it really happened, we could get a squeeze! I think they need the money for P, K and B but I’m hopeful the FDA meeting is this month or in Nov and we get BTD and can ink the deal. Fingers crossed for patients. B-OM will be a game changer for patients and hopefully prescribed for all head and neck cancer patients going thru the brutal high dose
IBD. Images were phenomenal on small data set. Why not throw that in if u were BP - just set milestones to lessen the risk.
Onward
It’s a great day. Ipix moves forward!
Prurisol data is coming bub
You are negative by nature here. Try looking at the positives. Ipix has upto 10 million from a family office. Not aspire.
BTD is currently under review with FDA. We should hear soon we were granted. Maybe today on top of this financing news
They will spin it every which way. Let them. Funding was needed. Let’s move B-OM into phase 3.
BTD coming. IMO.
This is a close to the company and already heavily invested family imo.
I will bet we see the SP skyrocket and no selling. This agreement allows the company to repurchase all preferred shares after the fact for 120% of value of issuance. 9 months of breathing room. Take b-OM into phase 3. Secure P data and partner up. Imo
He just closed on a 10 mil finance deal with friendly private family. Finally we move on. Another 9 months to move freely —- onward and upward. Bio. Was that you ;)
Excellent. More breathing room. $$$
I’d like to see Prurisol results now please :)
Enjoy your new adventures and investments. We will be here when the fun starts. Come on back when we are charging thru dollar land.
Everyone of those milestones will hit this year. I’m banking on it. However without the damn dilution from Aspire I’m hoping announce partnership. Announce BTD to help pump BPs investors and then drop P results. Just an estimated projection.
It’s hard to shine a turd but very easy to shine a gem. Ipix is just a tad bit dirty.
I think you and your friends are going to get crushed. You missed the Opportunity last year to partner for B. The idea of delaying and dropping out was a good try but we have a much better partner now. Bye bye
Nope. I think he is smart.
I have 2 other scenarios too;
One of which ——everything changed upon the Term Sheet in August. Adding an umbrella IBD indication is very powerful. Look at the low end 2 billion dollar deals recently up to the 8 billion dollar IBD deals. That is strong. Much much much stronger than OM alone. OM alone you were looking at 10-20 million upfront or so...with trial costs paid thru milestones potentially. With IBD....we are talking game changer and we could see the ink dry any day. IMO. Just prior to Nov presentation.
Second——BTD was initially denied and resubmitted - this could be what deal is waiting on.
IMO. IPIX needed cash fast. Possible reasons:
Legal Fees for Deal about to be signed.
Manufacturing Partners
CRO
More First Class Flights (wink)
IPIX got the money and set milestones that sounded great to the average investor...Milestones...wink
So the market jumped and aspire was able to unload from the .50s down on 8 million .25's. .......Great Return wink
No milestones were ever going to be hit...maybe 10% chance BTD
Retail fell as SP fell. Strong hands buying fear.
I think Leo is smart enough to know exactly what would really occur in the above scenario. I think Leo knows where this is going. Look out to those betting against.
Now through all doubt. IPIX will deliver and hit all milestones...all in the while saving 10's of millions of shares.
The End
We hit pay dirt$$$$$$$$$$$
Yes. I’m in based on my DD. A whole new level of confidence for sidelined folks will come and if the wait is too long for them, move on. Don’t sit on a board trashing it - that is childish to say it nicely.
There is a ton of money to be made on these products. Ipix has moved through the roughest phases. Drugs are safe and show a level of efficacy. That my friend is s great place to be.
Now, we just need a partner to help push them thru.
4 recent IBD deals. From 2.076 billion to 7+ billion. The market potential is awesome. Why all of a sudden is our BP suitor interested? Because they will get a better deal at this point to partner with iPIX to become a powerhouse instead of just OM.
Get ready and keep doing your own DD. There is no doomsday. We have a partner coming and they will add to our BOD and have a leash on us. However if iPIX drugs play out we ALL will be rich!! IMO.
NR. I do my own DD. If I relied on this board or share price of an OTC bio to tell the story I would be no where near as successful as I have been. This board could make you feel like you are throwing money into a toilet. I just bought 50k for 10k.
I did that and what has changed. We didn’t dilute 500 million shares. Actually we have gone up 10 million shares from last April?
You will see BTD, you will see FDA guidance and before Nov’s show we will have our partner announced.
Yes I’m super positive on this company. Because I think their pipeline far exceeds any other small bio I have ever seen.
Should we start posting pre clinical IBD deals? B OM will be a preventative 300-500 million a year first year drug.
Jmo. Of course
Bahaaaa. I will see a 600+ million deal before year end with double digit tiered royalties.
Yes. This board is toxic and has painted a false picture. Even with the several million shares traded down here we know that no new shares entered the market since June 29th. It’s literally retail who paid to see the milestones and then the 10-k projected not hitting them. Down since. This will jump just as fast right back to .50-.60 where it was once we start hitting those milestones imo.
A ton of longs picked up those cheapies.
I disagree. I’ve had one conversation a long time ago with the company. There is a line of interested parties. That is a fact and I have been told that. I do understand where people can feel that ipix has no life and is on its knees....but I honestly disagree. They need to make a stand and move to the next in quick order if they get one ounce of a stalling feeling. Knowing IBD is involved now. I think this is our suitor and I’m expecting a long healthy partnership. If we don’t hear a deal by Nov I’d say they moved on. IMO.
Aspire is not out. We are still in the original agreement and have 22 million left. Yes the share price needs to be at .25 or above....but the only agreement over is the milestone agreement where we basically got 2 million dollars in one day and gave up 8 million shares. That one is over. During that date range the original purchase agreement was on hold.
That two million will go towards lawyer fees for the 9 digit deal we are about to sign. IMO.